Oncogenic processes: a neglected parameter in the evolutionary ecology of animals by Thomas, Frédéric, Asselin, Klara, MacDonald, Nick, Brazier, Lionel, Meliani, Jordan, Ujvari, Beata, Dujon, Antoine Marie

“…Traditionally, cancer has been viewed primarily as a disease relevant to human and domesticated animal health, attracting attention mainly from oncologists. In recent years, however, the community of ecologists and evolutionary biologists has recognized the pivotal role of cancer-related issues in the evolutionary paths of various species, influencing multiple facets of their biology. …”
Get full text

The overview of modern approaches in treatment of triple negative breast cancer by A. A. Kharitonova, I. A. Smirnova, M. V. Kiseleva

“…The review presents the results of modern regimens of drug therapy of triple negative breast cancer according to the publications of domestic and foreign oncologists. On the basis of various clinical studies, the effectiveness of the use of anthracyclines, taxanes in the dose-dense regime, platinum preparations and other chemotherapy drugs for the treatment of triple-negative cancer has been shown. …”
Get full text

Bilateral Breast Masses with a Rare Etiology by Friederike Thieringer, Gideon Sartorius, Katrin Kalf, Viola Heinzelmann, Marcus Vetter

“…To our knowledge this is the first case reporting simultaneous involvement of breast, ovaries, and bones in Burkitt’s lymphoma. Gynecologists and oncologists should be aware of this pattern. Polychemotherapy treatment must be initiated rapidly with curative intent.…”
Get full text

Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option? by Christina Fotopoulou, Ioana Braicu, Jalid Sehouli

“…Next to the optimal therapeutic treatment strategies, gynecologic oncologists are being asked to incorporate into their decision-making processes the patients' wish for fertility preserving alternatives ideally without compromising oncologic safety. …”
Get full text

Fertility Preservation for Cancer Patients: A Review by Tosin Ajala, Junaid Rafi, Peter Larsen-Disney, Richard Howell

“…The parallel and continued improvement in both the management of oncology and fertility cases in recent times has brought to the fore-front the potential for fertility preservation in patients being treated for cancer. Oncologists must be aware of situations where their treatment will affect fertility in patients who are being treated for cancer and they must also be aware of the pathways available for procedures such as cryopreservation of gametes and/or embryos. …”
Get full text

Molecular Imaging to Identify Tumor Recurrence following Chemoradiation in a Hostile Surgical Environment by Olugbenga T. Okusanya, Charuhas Deshpande, Eduardo M. Barbosa, Charu Aggarwal, Charles B. Simone, Jack Jiang, Ryan Judy, Elizabeth DeJesus, Steve Albelda, Shuming Nie, Philip S. Low, Sunil Singhal

“…Surgical biopsy of potential tumor recurrence is a common challenge facing oncologists, surgeons, and cancer patients. Imaging modalities have limited ability to accurately detect recurrent cancer in fields affected by previous surgery, chemotherapy, or radiation. …”
Get full text

Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance by Onyekachi Henry Ogbonna, Marie Carmel Garcon, Kostas N. Syrigos, Muhammad Wasif Saif

“…Given the paucity of the cases of MANEC, continuous reporting of these cases when identified should be encouraged to aid oncologists in understanding the disease and help establish standardized management.…”
Get full text

Insights into Cancer-Associated Thrombosis Leading Towards Ischemic Stroke by Surajit Hansda, Hiranmoy Das

“…Overall, stroke is a significant and not uncommon complication of cancer, and there is an immediate demand for neurologists and oncologists to create strategies for screening and preventing strokes in cancer patients.…”
Get full text

Discussion on the mechanism of HER2 resistance in esophagogastric junction and gastric cancer in the era of immunotherapy by Yan Zhang, Wenxuan Fan, Fei Su, Xiaoling Zhang, Yunyi Du, Weiling Li, Yangjun Gao, Wenqing Hu, Jun Zhao

“…By integrating recent research findings and clinical trials, this review aims to provide oncologists and researchers with insights into developing more effective treatments for patients with drug-resistant HER2-positive G/GEJ cancer.…”
Get full text

Multidisciplinary Vulvar Cancer Management: The Dermatologist’s Perspective by Marta Cebolla-Verdugo, Victor Alfredo Cassini-Gómez de Cádiz, Juan Pablo Velasco-Amador, María Zulaika-Lloret, Francisco Manuel Almazán-Fernández, Ricardo Ruiz-Villaverde

“…Effective management requires a multidisciplinary approach, integrating the expertise of gynecologic oncologists, dermatologists, plastic surgeons, and other specialists. …”
Get full text

Necroptosis could serve as an indicator of therapeutic resistance in viral induced well-differentiated oral squamous cell carcinoma? by Nitya Krishnasamy, Ramya Ramadoss, Suganya Panneer Selvam, Sandhya Sundar, K. Hemashree

“…By understanding the relationship between necroptosis levels and therapeutic resistance, oncologists can aim to identify novel biomarkers and therapeutic targets that could improve patient management and outcomes in viral-induced OSCC. …”
Get full text

Artificial Intelligence in Oncology by Krzysztof Jeziorski, Robert Olszewski

“…The largest application of artificial intelligence in oncology is in diagnostics (more than 80%), particularly in radiology and pathology. This can help oncologists not only detect cancer at an early stage but also forecast the possible development of the disease by using predictive models. …”
Get full text

The Application of Differing Machine Learning Algorithms and Their Related Performance in Detecting Skin Cancers and Melanomas by Suboh Alkhushayni, Du’a Al-zaleq, Luwis Andradi, Patrick Flynn

“…With early detection being key to good outcomes, any method that can enhance the diagnostic accuracy of dermatologists and oncologists is of significant interest. When comparing different existing implementations of machine learning against public datasets and several we seek to create, we attempted to create a more accurate model that can be readily adapted to use in clinical settings. …”
Get full text

CURRENT POSSIBILITIES OF MAGNETIC – RESONANCE IMAGING IN DETECTION OF OVARIAN CANCER by N. A. Rubtsova, E. G. Novikova, I. Yu. Sychenkova

“…In connection with the above, timely diagnosis and organization of OC screening, as well as monitoring of its recurrence is a major problem for oncologists around the world.In the present literature review the opportunities of magnetic — resonance imaging (MRI) in detection of primary ovarian cancer and its recurrence are considered, the analysis of the method diagnostic efficiency based on the use of various techniques is done. …”
Get full text

Mental Health in Urologic Oncology by Danyon Anderson, Abrahim N. Razzak, Matthew McDonald, David Cao, Jamal Hasoon, Omar Viswanath, Alan D. Kaye, Ivan Urits

“…We hope that these measures conducted by urologists and oncologists, alongside possible coordination with psychiatrists and psychologists for psychotherapy, psychopharmacology, and neuro-stimulation treatment modems may be helpful in the long term to reduce MHI incidence in urology oncology patients. …”
Get full text

Physical and Psychological Impact of the Covid-19 Pandemic on Healthcare Workers, Including End of Life Care Providers by Toral Shastri, Kunal Gawri, Estelamari Rodriguez, Richa Dawar

“… # Objective The aim of this study was to gain more insight on the effect of COVID-19 on burnout among oncologists and other healthcare professionals at a large academic center…”
Get full text

Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy by Sarah Nikiforow, John Haanen, Omid Hamid, Igor Puzanov, Rodabe Amaria, Amod Sarnaik, Marcus O Butler, Michael R Bishop, Allison Betof Warner, Adam J Schoenfeld, Krishna Komanduri

“…This review includes clinical and toxicity management guidelines pertaining to the TIL cell therapy regimen prepared by the TIL Working Group, composed of internationally recognized hematologists and oncologists with expertize in TIL cell therapy, and relates to patient care and operational aspects. …”
Get full text

Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information by Laura E. Marin, Daniel I. Zavaleta-Guzman, Jessyca I. Gutierrez-Garcia, Daniel Racoceanu, Fanny L. Casado

“…Abstract Biopsy information and protein Prostate-Specific Antigen (PSA) levels are the most robust information available to oncologists worldwide to diagnose and decide therapies for prostate cancer patients. …”
Get full text

Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus by Emad Dawoud, Fathi Azribi, Aref Chehal, Shaheenah Dawood, Syed Hammad Tirmazy, Dina Hamza, Hassan Jaafar, Hussam Marashi

“…The objective of this paper is to establish a UAE-specific consensus among oncologists on practical T-DXd treatment considerations and management of associated side effects. …”
Get full text

Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion by Carmine Pinto, Sara Lonardi, Evaristo Maiello, Erika Martinelli, Michele Prisciandaro, Lisa Salvatore, Lisa Salvatore, Andrea Sartore-Bianchi, Andrea Sartore-Bianchi, Mario Scartozzi, Giuseppe Aprile, Chiara Cremolini, Alberto Sobrero

“…Several therapeutic options are now available, although some differences across countries in drug approval and the optimal therapeutic sequencing associated with each peculiar patient subgroup represent a clinical challenge for oncologists. Among various options, the SUNLIGHT trial showed how the combination of trifluridine/tipiracil (FTD/TPI) with bevacizumab is effective with an easily manageable toxicity profile compared to FTD/TPI alone. …”
Get full text